Cutler Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Cutler Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,400	Closed	-$22K	–	5048
2019 Q4	$22K	Sell	1,400 -800	-36%	-$92.7K	﹤0.01%	2173
2019 Q3	$41K	Buy	+2,200	New	+$219K	﹤0.01%	1701
2019 Q2	–	Sell	-1,300	Closed	-$13K	–	5143
2019 Q1	$13K	Buy	+1,300	New	+$106K	﹤0.01%	2360
2018 Q3	–	Sell	-2,800	Closed	-$30K	–	5105
2018 Q2	$30K	Buy	+2,800	New	+$242K	﹤0.01%	1939
2017 Q3	–	Sell	-11,500	Closed	-$12K	–	7362
2017 Q2	$12K	Buy	11,500 +600	+6%	+$67.1K	﹤0.01%	4027
2017 Q1	$2K	Buy	+10,900	New	+$1.16M	﹤0.01%	5692
2016 Q4	–	Sell	-9,900	Closed	-$6K	–	7884
2016 Q3	$6K	Sell	9,900 -8,100	-45%	-$956K	﹤0.01%	4879
2016 Q2	$1K	Buy	18,000 +10,500	+140%	+$1.22M	﹤0.01%	6471
2016 Q1	$13K	Buy	7,500 +3,600	+92%	+$422K	﹤0.01%	3804
2015 Q4	$147K	Buy	+3,900	New	+$450K	0.01%	1439

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Cutler Group's CBPO Position: Q4 2020 in Review

Cutler Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 9 shares — an estimated $1K sold.

Cutler Group first reported a position in CBPO in Q4 2015 and held it in 15 quarters. The position peaked at $7.62M in Q4 2016. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Cutler Group reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Cutler Group sold 9 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $1K.
Cutler Group first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 15 quarters.
Cutler Group's China Biologic Products Holdings, Inc. position peaked at $7.62M in Q4 2016.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.